KARNF yields 33.33% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, KARNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KARNF + JNJ for your $10,000?
Kernel Holding S.A., together with its subsidiaries, engages in the diversified agricultural business in Ukraine, Singapore, India, China, Switzerland, the Netherlands, and internationally. It operates through three segments: Oilseed Processing, Infrastructure and Trading, and Farming. The Oilseed Processing segment is involved in the origination, production, and sale of bottled and bulk sunflower oil, and meal products; and production of renewable energy from biomass. The Infrastructure and Trading segment provides grain handling, and logistics and transshipment services; grain and oilseed cleaning, drying, and storage services; and proprietary trading and silo services, as well as sourcing and merchandising services of wholesale edible oils and grains. The Farming segment engages in agricultural farming; and the production of corn, wheat, soybean, sunflower seed, and rapeseed. Kernel Holding S.A. was founded in 1995 and is headquartered in Kyiv, Ukraine.
Full KARNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.